PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry

CompletedOBSERVATIONAL
Enrollment

1,360

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2024

Conditions
Patent Foramen OvaleStroke, CryptogenicTransient Ischaemic Attack Due to EmbolismAtrial Fibrillation New Onset
Interventions
DEVICE

Septal Occluder Device

Transcatheter PFO closure with any commercially available septal occluder device

All Listed Sponsors
collaborator

Centro Cardiologico Monzino

OTHER

collaborator

University Hospital Padova

OTHER

collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

collaborator

Azienda Policlinico Umberto I

OTHER

collaborator

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

collaborator

San Camillo Hospital, Rome

OTHER

collaborator

Clinica San Martino

UNKNOWN

collaborator

University Of Perugia

OTHER

collaborator

Maria Cecilia Hospital

OTHER

lead

IRCCS Ospedale San Raffaele

OTHER

NCT06504121 - PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry | Biotech Hunter | Biotech Hunter